"Toll-Free Number Labeling and Related Requirements for Over-the-Counter and Prescription Drugs Marketed With Approved Applications"
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 15, 2012
May 6, 2020
3dd055ae-75ac-4cc5-9844-15edd771787b
Related Documents
Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs
Guidance DocumentDecember 3, 2012Center for Drug Evaluation and Research
Topical Acne Drug Products for Over-the-Counter Human Use--Revision of Labeling and Classification of Benzoyl Peroxide as Safe and Effective: Guidance for Industry
Guidance DocumentJune 21, 2011Center for Drug Evaluation and Research
Organ-Specific Warnings: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use — Small Entity Compliance Guide
Guidance DocumentAugust 17, 2010Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox